시장보고서
상품코드
1154085

세계의 프로테오믹스 시장(2023-2032년) : 시장 규모, COVID-19의 영향, 지역별 전망, 용도의 잠재성, 가격 동향, 경쟁 시장 점유율, 예측

Proteomics Market Size By Component, By Technique, By Application, By End-use, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032

발행일: | 리서치사: Global Market Insights Inc. | 페이지 정보: 영문 250 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 프로테오믹스 시장은 2차원 전기영동 단백질 분석기를 포함한 기술적으로 첨단 장비의 개발로 2023년부터 2032년까지 크게 성장할 것으로 예측됩니다.

또한 바이오칩과 같은 엔지니어링 장치의 통합은 생물학적 연구의 처리량과 효율성, 워크플로우 및 속도를 향상시킬 수 있습니다. 이러한 기술 혁신은 단백질 공학 시설의 확장 프로젝트에 대한 투자가 증가함에 따라 프로테오믹스 분석을 향상시킬 것으로 예상됩니다.

컴포넌트별로 보면 장비 부문의 점유율이 예측 기간 동안 크게 확대될 전망입니다. 초고속 질량 분석기와 자동 단백질 소화 플랫폼을 이용할 수 있어 클라우드 기반의 인포매틱스가 혁신된 것이 분자·세포 프로테오믹스의 발전에 크게 기여하고 있습니다.

세계의 프로테오믹스(Proteomics) 시장을 조사했으며, 시장 개요/시장 성장에 대한 각종 영향요인 분석/기술 정세/시장 규모의 추이·예측/각종 구분·지역 및 주요 국가별 내역/경쟁 환경/주요 기업 개요 등을 정리했습니다.

목차

제1장 조사 방법·조사 범위

제2장 주요 요약

제3장 프로테오믹스 산업 고찰

  • 산업의 분류
  • 산업 상황
  • 산업에 미치는 영향 요인
    • 촉진 요인
    • 잠재적 위험 및 과제
  • 성장성 분석
  • COVID-19 : 영향 분석
  • 신흥 기술의 상황
  • 프로테오믹스 프레임워크
  • 기술 상황
  • Porter’s Five Forces
  • PESTEL 분석

제4장 경쟁 상황

  • 기업 매트릭스 분석
  • 기업의 시장 점유율 분석
  • 전략 대시보드

제5장 프로테오믹스 시장 : 컴포넌트별

  • 주요 동향
  • 기기
  • 소모품
  • 서비스

제6장 프로테오믹스 시장 : 기술별

  • 주요 동향
  • 첨단 기술
    • 질량 분석
    • 젤 기반 기술
    • 단백질 마이크로어레이
    • 기타
  • 기존 기술
    • ELISA
    • 크로마토그래피 기반 기술
    • 에드먼 시퀀싱
    • 웨스턴 블롯팅
  • 바이오인포매틱스 분석
  • 기타

제7장 프로테오믹스 시장 : 용도별

  • 주요 동향
  • 임상 연구
  • 임상 진단

제8장 프로테오믹스 시장 : 최종 사용자별

  • 주요 동향
  • 의약품·바이오 의약품 기업
  • 학술·연구기관
  • 실험실
  • 기타

제9장 프로테오믹스 시장 : 지역별

  • 주요 동향
  • 북미
  • 유럽
  • 아시아 태평양
  • 남미
  • 중동·아프리카

제10장 기업 개요

  • Olink
  • SomaLogic Operating Co.
  • Biognosys AG
  • Agilent Technologies, Inc
  • Thermo Fisher Scientific
  • Bruker
  • Promega Corporation
  • Bio-Rad Laboratories
  • Creative Proteomics
  • Seer, Inc
  • Quantum-Si, Inc
  • PREOMICS GMBH
LYJ 22.11.23

The global proteomics market value is projected to rise substantially over 2023-2032, owing to the development of technologically advanced instruments including 2D electrophoresis protein analyzers.

The integration of engineered devices such as biochips can improve the throughput and efficiency of biological research, workflow, and speed. Such tech innovations, along with the mounting investment in protein engineering facility expansion projects, are expected to boost proteomics analysis.

Citing an instance, in February 2022, the NIH's National Institute of General Medical Sciences announced funding to establish a Genetic Code Expansion Center in Oregon. This facility was intended to revolutionize protein-focused biomedical and material research and solidify the state's status as a leader in the advancement of protein engineering. Initiatives such as these are likely to increase the reliance on engineered proteins for selective proteomics research applications.

The proteomics industry is categorized in terms of component, technique, application, end-use, and regional landscape.

Based on the component, the market share from the instruments segment is set to grow considerably over the forecast period. The availability of ultra-fast mass spectrometers and automated protein digestion platforms to innovate cloud-based informatics is a key contributor to molecular and cellular proteomics development.

In addition, proteomics facilities are equipped with state-of-the-art equipment and bioinformatics tools for data evaluation and interpretation. Such factors are anticipated to proliferate the advancement of proteomics technologies.

Proteomics market size from the conventional technique segment is slated to rise by 2032. This is on account of innovations in liquid chromatography that allow efficient analysis of proteomes of single cells. Several lab instrument manufacturing companies are also focused on launching chromatography solutions to support life science research, driving the adoption of clinical proteomics.

Based on the application, the industry share from the clinical diagnosis segment is poised to depict a strong growth rate through 2032, due to the surge in vaccine-preventable disease outbreaks. As per the WHO, in Africa, over 17,500 cases of measles were reported between January and March 2022, indicating a 400% rise from a year earlier. This growing disease burden is likely to increase the reliance on proteomics to discover biomarkers that indicate a particular disease.

Global proteomics industry value from the other end-use segment, including hospitals and research organizations, is projected to be worth more than USD 7.5 billion by 2032, owing to the increase in healthcare research funding.

For example, in October 2022, the NIHR Oxford BRC and the NIHR Oxford Health BRC obtained over USD 136.5 million in government funding to support 15 research themes over the next 5 years. These funds are slated to assert a positive impact on the proteomics industry outlook globally.

On the regional front, North America accounted for more than 47.5% share of the proteomics market in 2022, given the strong presence of key players and constant government support for proteomics research.

Asia Pacific proteomics industry size is also anticipated to witness an upsurge by 2032, considering the introduction of novel drug discovery projects for chronic diseases and the development of innovative mass spectrometers.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definition
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Proteomics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Component trends
    • 2.1.3 Technique trends
    • 2.1.4 Application trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Proteomics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing demand for personalized medicine
      • 3.3.1.2 Government funding
      • 3.3.1.3 Rising R&D expenditure
      • 3.3.1.4 Technological advancements
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost of instrument
      • 3.3.2.2 Shortage of skilled professionals
  • 3.4 Growth potential analysis
    • 3.4.1 By component
    • 3.4.2 By technique
    • 3.4.3 By application
    • 3.4.4 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Emerging technology landscape
  • 3.7 Proteomics framework
  • 3.8 Technology landscape
  • 3.9 Porter's analysis
    • 3.9.1 Industry rivalry
    • 3.9.2 Buyer power
    • 3.9.3 Supplier power
    • 3.9.4 Threat of substitute
    • 3.9.5 Threat of new entrants
  • 3.10 PESTEL analysis
    • 3.10.1 Political
    • 3.10.2 Economical
    • 3.10.3 Social
    • 3.10.4 Technological
    • 3.10.5 Environmental
    • 3.10.6 Legal

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Company market share analysis, by instruments
    • 4.3.2 Company market share analysis, by services
  • 4.4 Strategic dashboard

Chapter 5 Proteomics Market, By Component

  • 5.1 Key segment trends
  • 5.2 Instruments
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.3 Consumables
    • 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.4 Services
    • 5.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Proteomics Market, By Technique

  • 6.1 Key segment trends
  • 6.2 Advanced technique
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.2 Mass spectrometry
      • 6.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.3 Gel-based technique
      • 6.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.4 Protein microarray
      • 6.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.5 Others
      • 6.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 Conventional technique
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.2 ELISA
      • 6.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.3 Chromatography based technique
      • 6.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.4 Edman sequencing
      • 6.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.5 Western blotting
      • 6.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.4 Bioinformatics analysis
    • 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.5 Others
    • 6.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Proteomics Market, By Application

  • 7.1 Key segment trends
  • 7.2 Clinical research
    • 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.3 Clinical diagnosis
    • 7.3.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Proteomics Market, By End-use

  • 8.1 Key segment trends
  • 8.2 Pharmaceutical & biopharmaceutical companies
    • 8.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 8.3 Academic & research institute
    • 8.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 8.4 Laboratories
    • 8.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 8.5 Others
    • 8.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 9 Proteomics Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 Market size, by country, 2018 - 2032 (USD Million)
    • 9.2.2 Market size, by component, 2018 - 2032 (USD Million)
    • 9.2.3 Market size, by technique, 2018 - 2032 (USD Million)
      • 9.2.3.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
      • 9.2.3.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
    • 9.2.4 Market size, by application, 2018 - 2032 (USD Million)
    • 9.2.5 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.2.6 U.S.
      • 9.2.6.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.2.6.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.2.6.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.2.6.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.2.6.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.2.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.2.7 Canada
      • 9.2.7.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.2.7.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.2.7.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.2.7.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.2.7.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.2.7.4 Market size, by end-use, 2018 - 2032 (USD Million)
  • 9.3 Europe
    • 9.3.1 Market size, by country, 2018 - 2032 (USD Million)
    • 9.3.2 Market size, by component, 2018 - 2032 (USD Million)
    • 9.3.3 Market size, by technique, 2018 - 2032 (USD Million)
      • 9.3.3.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
      • 9.3.3.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
    • 9.3.4 Market size, by application, 2018 - 2032 (USD Million)
    • 9.3.5 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.3.6 Germany
      • 9.3.6.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.3.6.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.3.6.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.3.6.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.3.6.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.3.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.3.7 UK
      • 9.3.7.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.3.7.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.3.7.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.3.7.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.3.7.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.3.7.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.3.8 France
      • 9.3.8.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.3.8.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.3.8.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.3.8.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.3.8.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.3.8.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.3.9 Italy
      • 9.3.9.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.3.9.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.3.9.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.3.9.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.3.9.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.3.9.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.3.10 Spain
      • 9.3.10.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.3.10.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.3.10.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.3.10.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.3.10.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.3.10.4 Market size, by end-use, 2018 - 2032 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Market size, by country, 2018 - 2032 (USD Million)
    • 9.4.2 Market size, by component, 2018 - 2032 (USD Million)
    • 9.4.3 Market size, by technique, 2018 - 2032 (USD Million)
      • 9.4.3.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
      • 9.4.3.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
    • 9.4.4 Market size, by application, 2018 - 2032 (USD Million)
    • 9.4.5 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.4.6 Japan
      • 9.4.6.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.4.6.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.4.6.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.4.6.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.4.6.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.4.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.4.7 China
      • 9.4.7.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.4.7.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.4.7.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.4.7.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.4.7.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.4.7.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.4.8 India
      • 9.4.8.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.4.8.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.4.8.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.4.8.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.4.8.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.4.8.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.4.9 Australia
      • 9.4.9.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.4.9.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.4.9.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.4.9.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.4.9.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.4.9.4 Market size, by end-use, 2018 - 2032 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Market size, by country, 2018 - 2032 (USD Million)
    • 9.5.2 Market size, by component, 2018 - 2032 (USD Million)
    • 9.5.3 Market size, by technique, 2018 - 2032 (USD Million)
      • 9.5.3.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
      • 9.5.3.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
    • 9.5.4 Market size, by application, 2018 - 2032 (USD Million)
    • 9.5.5 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.5.6 Brazil
      • 9.5.6.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.5.6.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.5.6.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.5.6.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.5.6.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.5.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.5.7 Mexico
      • 9.5.7.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.5.7.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.5.7.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.5.7.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.5.7.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.5.7.4 Market size, by end-use, 2018 - 2032 (USD Million)
  • 9.6 MEA
    • 9.6.1 Market size, by country, 2018 - 2032 (USD Million)
    • 9.6.2 Market size, by component, 2018 - 2032 (USD Million)
    • 9.6.3 Market size, by technique, 2018 - 2032 (USD Million)
      • 9.6.3.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
      • 9.6.3.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
    • 9.6.4 Market size, by application, 2018 - 2032 (USD Million)
    • 9.6.5 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.6.6 South Africa
      • 9.6.6.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.6.6.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.6.6.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.6.6.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.6.6.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.6.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
    • 9.6.7 Saudi Arabia
      • 9.6.7.1 Market size, by component, 2018 - 2032 (USD Million)
      • 9.6.7.2 Market size, by technique, 2018 - 2032 (USD Million)
        • 9.6.7.2.1 Market size, by advanced technique, 2018 - 2032 (USD Million)
        • 9.6.7.2.2 Market size, by conventional technique, 2018 - 2032 (USD Million)
      • 9.6.7.3 Market size, by application, 2018 - 2032 (USD Million)
      • 9.6.7.4 Market size, by end-use, 2018 - 2032 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Olink
    • 10.1.1 Business overview
    • 10.1.2 Financial data
    • 10.1.3 Product landscape
    • 10.1.4 Strategic outlook
    • 10.1.5 SWOT analysis
  • 10.2 SomaLogic Operating Co.
    • 10.2.1 Business overview
    • 10.2.2 Financial data
    • 10.2.3 Product landscape
    • 10.2.4 Strategic outlook
    • 10.2.5 SWOT analysis
  • 10.3 Biognosys AG
    • 10.3.1 Business overview
    • 10.3.2 Financial data
    • 10.3.3 Product landscape
    • 10.3.4 Strategic outlook
    • 10.3.5 SWOT analysis
  • 10.4 Agilent Technologies, Inc
    • 10.4.1 Business overview
    • 10.4.2 Financial data
    • 10.4.3 Product landscape
    • 10.4.4 Strategic outlook
    • 10.4.5 SWOT analysis
  • 10.5 Thermo Fisher Scientific
    • 10.5.1 Business overview
    • 10.5.2 Financial data
    • 10.5.3 Product landscape
    • 10.5.4 Strategic outlook
    • 10.5.5 SWOT analysis
  • 10.6 Bruker
    • 10.6.1 Business overview
    • 10.6.2 Financial data
    • 10.6.3 Product landscape
    • 10.6.4 Strategic outlook
    • 10.6.5 SWOT analysis
  • 10.7 Promega Corporation
    • 10.7.1 Business overview
    • 10.7.2 Financial data
    • 10.7.3 Product landscape
    • 10.7.4 Strategic outlook
    • 10.7.5 SWOT analysis
  • 10.8 Bio-Rad Laboratories
    • 10.8.1 Business overview
    • 10.8.2 Financial data
    • 10.8.3 Product landscape
    • 10.8.4 Strategic outlook
    • 10.8.5 SWOT analysis
  • 10.9 Creative Proteomics
    • 10.9.1 Business overview
    • 10.9.2 Financial data
    • 10.9.3 Product landscape
    • 10.9.4 Strategic outlook
    • 10.9.5 SWOT analysis
  • 10.10 Seer, Inc
    • 10.10.1 Business overview
    • 10.10.2 Financial data
    • 10.10.3 Product landscape
    • 10.10.4 Strategic outlook
    • 10.10.5 SWOT analysis
  • 10.11 Quantum-Si, Inc
    • 10.11.1 Business overview
    • 10.11.2 Financial data
    • 10.11.3 Product landscape
    • 10.11.4 Strategic outlook
    • 10.11.5 SWOT analysis
  • 10.12 PREOMICS GMBH
    • 10.12.1 Business overview
    • 10.12.2 Financial data
    • 10.12.3 Product landscape
    • 10.12.4 Strategic outlook
    • 10.12.5 SWOT analysis
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제